Vanda Pharmaceuticals (VNDA) Inventory (2012 - 2026)

Vanda Pharmaceuticals (VNDA) has 15 years of Inventory data on file, last reported at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 11.65% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 11.65% YoY), and the FY2025 full-year result was $11.0 million, up 15.84% from the prior year.
• Inventory slipped to $1.7 million in Q1 2026, from $11.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $11.5 million in Q4 2022 to a low of $1.3 million in Q1 2022.
• A 5-year average of $6.3 million and a median of $9.5 million in 2024 frame the typical range for Inventory.
• Peak annual rise in Inventory reached 728.53% in 2023, while the deepest fall reached 88.19% in 2023.
• Tracing VNDA's Inventory over 5 years: stood at $11.5 million in 2022, then tumbled by 88.19% to $1.4 million in 2023, then surged by 601.03% to $9.5 million in 2024, then increased by 15.84% to $11.0 million in 2025, then plunged by 84.58% to $1.7 million in 2026.
• Business Quant data shows VNDA's Inventory at $1.7 million in Q1 2026, $11.0 million in Q4 2025, and $10.0 million in Q3 2025.